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Natural killer (NK) cells are important in the immune defense against tumor cells and
pathogens, and they regulate other immune cells by cytokine secretion. AlthoughmurineNK
cell biology has been extensively studied, knowledge about transcriptional circuitries con-
trolling human NK cell development and maturation is limited. By generating ETS1-deficient
human embryonic stem cells and by expressing the dominant-negative ETS1 p27 isoform in
cord blood hematopoietic progenitor cells, we show that the transcription factor ETS1 is
critically required for human NK cell differentiation. Genome-wide transcriptome analysis
determined by RNA-sequencing combinedwith chromatin immunoprecipitation–sequencing
analysis reveals that human ETS1directly induces expression of key transcription factors that
control NK cell differentiation (ie, E4BP4, TXNIP, TBET, GATA3,HOBIT, BLIMP1). In addition,
ETS1 regulates expression of genes involved in apoptosis and NK cell activation. Our study
provides importantmolecular insights into the role of ETS1 as an important regulator of human
NK cell development and terminal differentiation. (Blood. 2020;136(3):288-298)
Introduction
Natural killer (NK) cells play a crucial role in the defense against
viral infections and carcinogenesis through lysis of infected or
transformed cells. Via secretion of cytokines, they also regulate T
and B cells.1 In patients with acute myeloid leukemia, trans-
planted donor NK cells expressing mismatched inhibitory re-
ceptors provide a graft-versus-leukemia effect in the absence of
graft-versus-host disease.2 There are several ongoing studies
and clinical trials for NK cell immunotherapy as treatment for
leukemia and solid cancers.3
Differentiation and lineage specification of hematopoietic pro-
genitor cells (HPCs) into myeloid and lymphoid cells is regulated
by transcription factors. NK cells are derived from common
lymphoid progenitors (CLPs). NK cell progenitors (NKPs) express
CD122, become interleukin-15 (IL-15) responsive, and are NK cell
restricted. During further differentiation, inhibitory and activating
NK cell receptors are expressed, and functional capabilities, such
as cytotoxicity and cytokine secretion, are eventually acquired. In
contrast tomouse, detailed knowledge of the regulation of human
NK cell differentiation is lacking. Due to increased interest in NK
cells as therapeutic agents, a more complete understanding of
the molecular basis of human NK cell differentiation is desirable.
However, because there are important differences between
mouse and human NK differentiation, human models remain
essential for translational purposes.
The transcription factor ETS1 is predominantly expressed in
lymphoid cells. Ets12/2 mice have reduced NK cell numbers that
display lower cytolytic activity.4,5 The role of ETS1 in human NK
cell biology remains unknown. There are 3 human ETS1 iso-
forms: ETS1 p51, encoded by exons I to VII; ETS1 p42, lacking
the sequences encoded in exon VII; and ETS1 p27, lacking the
sequences encoded in exons III to VI.6-8 ETS1 p42 acts as a gain-
of-function protein because the autoinhibitory motif that
suppresses DNA binding is absent. ETS1 p27 possesses the
DNA-binding domain flanked by inhibitory domains but lacks
the Pointed and the transactivation domains, which are re-
quired for the transactivation of ETS1 target genes. It has been
shown that ETS1 p27 binds DNA in the same way as ETS1 p51,
but it has a dual-acting dominant-negative effect because it
not only acts at the transcriptional level by blocking ETS1
p51–mediated transactivation of target genes but also affects
the subcellular localization by inducing the translocation of
ETS1 p51 from the nucleus to the cytoplasm.
Here, we reveal the role of ETS1 in human NK cell differentiation
and terminaldifferentiationbyperformingknockout, loss-of-function,
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and overexpression experiments. NK cell differentiation is
inhibited as a consequence of absent or reduced ETS1 function.
Transcriptome and chromatin immunoprecipitation–sequencing
(ChIP-seq) analysis reveals that ETS1 directly induces ex-
pression of 6 key transcription factors that have been pre-
viously reported to control NK cell differentiation and/or
maturation. Finally, residual NK cells in ETS1 loss-of-function
display defective cytotoxicity and cytokine production on
tumor cell contact, presumably due to reduced expression of
activating NK cell receptors. Our data provide molecular in-
sights into the role of ETS1 as a critical regulator of human NK
cell biology.
Methods
ETS1-deficient human embryonic stem cells and
hematopoietic differentiation
WA01 human embryonic stem cells (hESCs) were kept in an
undifferentiated state using the hESC medium (KOSR)/MEF
platform/WiCell Feeder Dependent Protocol (https://www.
wicell.org/). Single-cell–adapted hESCs were generated as
described9 and used to generate ETS12/2 hESCs via CRISPR/
Cas9 technology10,11 targeting exon A/1. Detailed information is
presented in the supplemental Methods (available on the Blood
Web site).
Umbilical cord blood HPC differentiation
CD341 HPCs were in vitro differentiated into NK cells as de-
scribed by Cichocki and Miller,12 with modifications (supple-
mental Methods).
Viral constructs
Complementary DNA encoding human ETS1 p51 or ETS1 p27
was subcloned from the pLEXhETS1p51HAtag (kindly pro-
vided by L.A. Garrett-Sinha, State University of New York,
Buffalo, NY) and pCDNA3hETS1p27 vector8 into the LZRS–
internal ribosome entry site–enhanced green fluorescent
protein (eGFP) retroviral vector.13 The empty LZRS–internal
ribosome entry site–eGFP vector was used as control. Virus was
generated as described.
Flow cytometry
Cultures were evaluated by using an LSRII flow cytometer, and
data were analyzed with the FACSDiva Version 6.1.2 (both from
BD Biosciences, San Jose, CA) and/or FlowJo_V10 software
(Ashland, OR). The antibodies used are listed in the supple-
mental Methods.
Functional assays
Interferon-g assays For intracellular interferon-g (IFN-g) flow
cytometric detection, cells from day 21 (d21) cocultures were
stimulated with K562 cells at a 1:1 ratio for 6 hours or with IL-12/
IL-18 (both 10 ng/mL) or IL-12/IL-15 (4 ng/mL)/IL-18 for 24 hours.
Brefeldin A (BD GolgiPlug; BD Biosciences) was added during
the last 4 hours. NK cell surface marker staining was performed;
cells were then fixed and permeabilized (Cytofix/Cytoperm Kit;
BD Biosciences) and stained for IFN-g.
For detectionof secreted IFN-g, eGFP1CD451CD11a1CD561CD941
NK cells were sorted from d21 cultures using an FACSAria III cell
sorter (BD Biosciences) and stimulated with IL-12/IL-18 or IL-12/
IL-15/IL-18 for 24 hours. Secreted IFN-g was quantified by using
the human IFN-g enzyme-linked immunosorbent assay PeliKine-
Tool set (Sanquin, Amsterdam, The Netherlands).
CD107a detection assay Cells from d18 to d21 cocultures were
stimulated by coculture with K562 cells (ATCC, Manassas, VA)
during 2 hours, as described by Bryceson et al.14
51Chromium release assay K562 target cells were labeled with
Na251CrO4 (PerkinElmer, Waltham, MA). eGFP1CD451CD11a1CD941
NK cells were sorted from d18 to d21 cocultures and added at
various ratios to 51chromium-labeled K562 cells. After 4 hours,
supernatant was harvested and measured in a 1450 LSC&Lu-
minescence Counter (Wallac MicroBeta TriLux; PerkinElmer).
The mean percentage of specific lysis of triplicate wells was
calculated.
Library preparation, sequencing, quantitative
polymerase chain reaction, and identification of
putative ETS1-binding sites
Viable d18 eGFP1CD451CD11a1CD561CD941 NK cells were
sorted to perform transcriptome analysis. Samples were se-
quenced with high-throughput NextSeq 500 (Illumina, San
Diego, CA) flow cell–generating 75 bp single reads. Differential
expression analysis was performed by using DESeq2. Details can
be found in the supplemental Methods.
For ChIP-seq, sorted viable peripheral blood NK cells were
crosslinked in 1% formaldehyde. Protein-DNA complexes were
immunoprecipitated with rabbit polyclonal anti-ETS1 antibody
(ActiveMotif, Carlsbad, CA). Immune complexes were isolated with
protein A agarose beads (Thermo Fisher Scientific, Waltham, MA).
Crosslinks were reversed at 65°C. After DNA purification, Illumina
sequencing libraries were prepared from the ChIP and input DNAs
by the standard consecutive enzymatic steps of end-polishing,
dA-addition, and adaptor ligation. After a final polymerase chain
reaction amplification step, the resulting DNA libraries were
quantified and sequenced on an Illumina NextSeq 500 system. The
supplemental Methods provide detailed information. Putative
ETS1-binding sites in promotors and enhancers were detected by
analysis using MACS2 and HOMER software.15,16
Statistical analysis
Statistical analysis was performed by using SPSS version 24
software (IBM SPSS Statistics, IBM Corporation, Armonk, NY). A
P value generated by a Student t test ,.05 was considered
statistically significant.
Results
Strongly reduced capacity of ETS1 knockout hESCs
to differentiate into NK cells
An ETS1-specific guide RNA was selected that efficiently gen-
erated ETS1 knockout clones by usingCRISPR/Cas9 technology in
Jurkat cells (supplemental Figure 1). Using the same guide RNA in
hESCs, we selected 3 hESC ETS12/2 clones (15.3, 17.3, and 21.1)
that carried nucleotide deletions resulting in a biallelic frameshift.
The wild-type clone (16.1) underwent similar selection processes
(Figure 1A). hESC clones were differentiated into HPCs (CD341
CD431). Homozygous ETS1deficiency hadno significant effect on
absolute HPC numbers (Figure 1B). hESC-derived HPCs were
cultured in NK differentiation conditions. Wild-type hESCs effi-
ciently generated NK cells, confirming earlier studies17; however,
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significantly fewer NK cells were generated from each ETS12/2
clone (Figure 1C-D). Thus, although ETS1 is not required for
differentiation of hESCs into HPCs, it is crucial for NK cell de-
velopment thereof.
ETS1 expression is essential for human NK cell
differentiation from cord blood HPCs
HPCs generated from hESCs resemble yolk sac hematopoietic
progenitors with limited stem cell activity.18 We therefore also
studied the role of ETS1 in NK differentiation from cord blood
(CB) HPCs, which are considered bona fide HPCs. We trans-
duced dominant-negative ETS1 p27 and full-length ETS1 p51
into CB HPCs, next to a vector control, and stable over-
expression was observed (supplemental Figure 2A-D). ETS1 p27
transduction resulted in strong reduction of NK cell numbers
(gated as shown in supplemental Figure 3A), whereas ETS1 p51
overexpression had no effect (Figure 2A). Because we observed
less mature NK cells in ETS1 loss-of-function conditions, we
investigated whether ETS1 affects earlier NK developmental
stages. Although stage 1 cells (CD341CD45RA1CD117–) (gating
shown in supplemental Figure 3B) were not affected, stage 2
cells (CD341CD45RA1CD1171) displayed a trend in lower cell
numbers in ETS1 p27 cultures, which became significant in stage
3 cells (CD34–CD1171CD94–NKp44–) (Figure 2B). These results
show that ETS1 is an essential factor in humanNK cell generation
from CB HPCs starting at stage 3.
ETS1 regulates expression of key transcription
factors linked to NK cell differentiation
To achieve mechanistic insight, the genome-wide transcriptome
of sorted ETS1 p27 vs control NK cells was determined by RNA-
sequencing. A total of 1178 differentially expressed genes were
identified (Figure 3A). ETS1 p27 NK cells displayed down-
regulated expression of molecules related to lymphocyte dif-
ferentiation (supplemental Figure 4). Strikingly, several key
transcription factors of murine and/or human NK cell differen-
tiation were repressed; that is, GATA3, HOBIT (ZNF683), TBET
(TBX21), TXNIP, E4BP4 (NFIL3), and BLIMP1 (PRDM1). Inversely,
AIOLOS (IKZF3) and EOMES (EOMESODERMIN) were upre-
gulated. This was confirmed by quantitative polymerase chain
reaction and/or flow cytometry (Figure 3B-D).
Expression of these 8 transcription factors was also tested in the
precursor stages. Nonewas differentially expressed at stage 1. In
ETS1 p27 stage 2 cells, GATA3 expression was significantly
reduced, whereas it was increased at stage 3. At stage 3,HOBIT,
TBET, andAIOLOS expression was reduced in ETS1 p27 cultures
(Figure 3B-C).
Thus, ETS1 p27 first affects GATA3 (from stage 2), then HOBIT,
TBET, and AIOLOS (from stage 3); at the mature NK cell stage,
the expression of all 8 transcription factors is compromised.
A
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Figure 1. ETS1 deletion in human embryonic stem cells severely impairs NK cell development. (A) Three homozygous ETS1 knockout (ETS12/2) hESC clones were
generated by using CRISPR/Cas9 technology to introduce mutations in exon A/1 by non-homologous end joining. The wild-type (WT) clone underwent the same selection
processes. The sequence of the targeted region of exon A/1 is indicated for both alleles, showing biallelic frameshifts in the knockout clones. (B) WT and mutated hESCs were
differentiated into hematopoietic CD341CD431 progenitor cells. Cell numbers are indicated (mean6 SEM; n5 4-6). (C-D) CD341CD431 cells were subsequently cultured in NK
cell–differentiating conditions. (C) The ratio of the cell numbers of generatedNK cells (gated as CD451CD561CD941) over the input precursor stem cell number was determined
(mean6 SEM; n5 4-6) on d14 and d21. (D) Representative dot plots of d21 cultures are shown, with the indicated NK cell percentage in the CD451 gated population. Significant
difference compared with the WT clone, *P , .05 (Student t test).
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Multiple key NK cell–linked transcription factors
are direct ETS1 targets
Although ETS1 ChIP data are available for human non-NK im-
mune subpopulations and cell lines, they were not available for
murine or human NK cells. Because it is well known that target
genes of transcription factors are cell type specific, we per-
formed ETS1 ChIP-seq on unmanipulated human NK cells and
detected 7738 ETS1 peaks. The primary motif identified was
ETS1, validating the ChIP-seq experiment, followed by ETS1:
RUNX and RUNX motifs (Figure 4A). This is in line with previous
findings that ETS1 and RUNX1 bind in a cooperative manner to
large cohorts of enhancers controlling T lineage commitment.19
The TBETmotif was also enriched, albeit with lower significance.
This outcome suggests that these transcription factors share
regulatory regions. The ETS1-binding motif was mainly found
within promoter regions (Figure 4B), whereas RUNX and TBET
motifs were enriched in enhancers (data not shown). This indi-
cates that differential complex formation provides a mechanism
by which ETS1 can be directed to other genomic locations.
Importantly, combined analysis of the ETS1 ChIP-seq data with
available ATAC-sequencing, as well as H3K4me3 and H3K27ac
ChIP-seq data from human NK cells,20 revealed that ETS1
ChIP peaks were present in promotors or enhancers of the
aforementioned ETS1-regulatedNK cell–linked key transcription
factors (Figure 4C; supplemental Table 1).
There was a 44% and 48% overlap between ETS1 ChIP-seq
peaks and ETS1 p27 downregulated and upregulated genes,
respectively (Figure 4D). Nonbiased analysis of enriched tran-
scription factor motifs21 in ETS1 p27 downregulated and upre-
gulated genes shows that motifs for BLIMP1, E4BP4, GATA3,
and HOBIT were significantly enriched (Figure 4E).
Thus, several transcription factors identified by others to be
important in NK cell biology are differentially expressed in ETS1
loss-of-function conditions, and ChIP data indicate that these are
direct ETS1 targets. In addition, whereas part of the differentially
expressed genes overlap with the ETS1 ChIP peaks, motifs of
several of the differentially expressed NK cell–linked transcrip-
tion factors are also enriched in downregulated and upregulated
genes of the ETS1 p27 cultures.
Increased apoptosis in NK cells from ETS1 p27
cultures
We investigated whether the lower NK cell number in the ETS1
p27 cultures (Figure 2) resulted from increased apoptosis and/or
decreased proliferation. The programmed cell death pathway
was enriched in the upregulated genes of ETS1 p27 NK cells
(supplemental Figure 5). Quantitative polymerase chain reaction
confirmed higher expression of the proapoptotic gene PMAIP-1
and lower expression of several antiapoptotic genes, including
TSC22D3, BIRC3, and PIM2, in ETS1 p27 cultures (Figure 5A).
This corresponded to increased apoptosis in ETS1 p27 NK cells
(Figure 5B). In addition, ChIP-seq analysis revealed that anti-
apoptotic genes are direct ETS1 targets (supplemental Table 1).
The mitosis pathway was enriched in ETS1 p27 upregulated
genes (Figure 5C), suggesting that proliferation would be in-
creased. However, further analysis showed that the majority of
these upregulated genes negatively regulate mitosis (Figure 5D;
supplemental Table 2). Cell cycle analysis showed that the
percentage of nonproliferating (G0) cells was not different in
ETS1 p27 vs control NK cells. In proliferating cells, there was a
small significant decrease in G1 cells and an increase at the G2/
M phase (Figure 5E). We observed similar proliferation rates in
cell trace experiments starting at d14 of culture and analyzed
after 7 days (data not shown).
Thus, increased apoptosis results in reduced NK cell numbers in
ETS1 p27 cultures.
ETS1 is required for NK cell cytotoxicity and IFN-g
production upon tumor cell recognition
NK-mediated cytotoxicity is one of the significant pathways of
downregulated genes in ETS1 p27 NK cells (Figure 5C). Because
activating receptors trigger NK cell cytotoxicity, we first analyzed
NKG2D, NKp30, NKp44, and NKp46 expression. Whereas
NKG2D expression was unaffected, NKp30, NKp44, and NKp46
expression was decreased in ETS1 p27 NK cells (Figure 6A). KIR
receptor expression did not differ from that of control NK cells
(Figure 6B). Functionally, ETS1 p27 NK cells displayed less ef-
fective degranulation upon K562 coculture (Figure 6C), as well as
reduced killing (Figure 6D). However, perforin and granzyme B
protein levels tended to be higher (Figure 6E). The lower cy-
















































































Figure 2. ETS1 loss-of-function in CB HPC inhibits NK cell differentiation. (A)
Upon transduction with control (ctrl), ETS1 p27, or ETS1 p51 vectors, sorted CB
CD341Lin–eGFP1 precursor cells were cultured in NK cell–differentiating condi-
tions. Absolute cell numbers of NK cells were determined at the indicated time
points. (B) Absolute cell numbers of differentiation stage 1 to stage 3 were de-
termined at d14. Data are presented as mean 6 SEM, and the number of ex-
periments is indicated. Significant difference compared with ctrl, *P, .05 (Student
t test).
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pathways, as Fas ligand expression was not different in control
vs ETS1 p27 cultures; this was true for unstimulated and
K562 target-stimulated NK cells (Figure 6F). TRAIL expression
was undetectable (data not shown).
To analyze the role of ETS1 in IFN-g production, cells were
stimulated with K562 target cells. This process resulted in lower
IFN-g production in ETS1 p27 NK cells compared with
the control (Figure 6G). Upon stimulation with IL-12/IL-18 or IL-
12/IL-15/IL-18, no significant trend occurred in increased IFN-g
production by ETS1 p27 NK cells, as evidenced by intracellular
IFN-g analysis, and IFN-g secretion was significantly higher upon
IL-12/IL-15/IL-18 stimulation as measured by using enzyme-
linked immunosorbent assay (Figure 6H).
Thus, ETS1 loss-of-function inhibits expression of several activating
NK cell receptors and reduces granule-mediated cytotoxicity and
tumor target–induced IFN-g production. Cytokine-induced IFN-g
production is not affected.
To study whether ETS1 is required to maintain NK cell func-
tionality, mature NK cells were analyzed upon transduction with
control vs ETS1 p27 retrovirus. Degranulation and cytotoxicity,
as well as IFN-g production and secretion, were not affected
(supplemental Figure 6). This scenario indicates that ETS1mainly
exerts its effects during NK cell differentiation and is not es-
sential to maintain the functionality of mature NK cells.
Discussion
Insight into the regulatory role of transcription factors in human
NK biology is still in its infancy. We found that ETS1 regulates
expression of several key transcription factors known to act at
different levels of NK cell development, including E4BP4, TBET,
TXNIP, GATA3, BLIMP1, HOBIT, AIOLOS, and EOMES. These
are direct ETS1 targets as determined by using ChIP-seq anal-
ysis. We therefore show that ETS1 is an important regulator of
human NK cell development and terminal differentiation.
Endogenous ETS1 expression is detectable at stages 1 and 2 of
human NK cell differentiation and rises at stage 3 to reach levels
equivalent to mature NK cells.22 This scenario is consistent with
our findings, which showed that ETS1 deficiency in hESCs does
not influence the generation of HPCs; also, ETS1 p27 in CBHPCs
does not affect development of stages 1 and 2, whereas stage 3
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Figure 3. ETS1 directly regulates expression of several key transcription factors linked to NK cell differentiation. (A) NK cells were sorted from d18 control and
ETS1 p27 cultures, and RNA-sequencing was performed. Volcano plot showing downregulated (blue) and upregulated (red) genes in NK cells from ETS1 p27 vs control (n5 4).
Differentially expressed NK cell–related transcription factors are indicated. (B-C) NK cell–linked transcription factors that were differentially expressed as shown in panel A were
evaluated by quantitative polymerase chain reaction analysis in all stages. Data are presented as mean6 SEM, and the number of experiments is indicated. (D) Representative
dot plots of flow cytometry analysis of TBET and EOMES expression in mature NK cells. The mean fluorescence intensity (MFI) 6 SEM (n 5 8) is shown. Significant difference
compared with control, *P , .05 and ***P , .001 (Student t test). mNK, mature NK cells.
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Figure 4. ETS1 ChIP analysis of human ex vivo peripheral NK cells. (A-D) ETS1 ChIP-seq analysis was performed on sorted human peripheral bloodNK cells. (A) Knownmotifs
were identified with the HOMER package, and the 4 most significant motifs are shown. (B) Locations of ETS1 ChIP peaks relative to genomic annotations. (C) Genome browser
tracks of NK cell–linked transcription factor genes are shown for human NK cell ETS1 ChIP-seq vs input DNA, vs H3K4me3 and H3K27ac ChIP-seq and ATAC-sequencing. (D)
Identification of the proportion of genes that are potentially directly regulated by ETS1. (E) Nonbiased analysis of enriched transcription factor motifs in the downregulated and
upregulated genes of ETS1 p27 NK cells by using the computational method iRegulon.
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are similar to what has been observed in Ets12/2 mice, in which
CLPs are not affected and pre-NKP and refined NK precursor
(rNKP) are decreased.5
We found that human ETS1 orchestrates expression of tran-
scription factors that play key roles in NK cell biology. Murine
E4bp4 controls NK cell commitment. E4bp42/2 mice display re-
duced development of CLPs into NK progenitors, having less
immature NK cells (NK1.11DX5–), and mature NK cells
(NK1.11DX51) are almost absent.23-25 The requirement for E4bp4
inNK cell differentiation is restricted toNKPs, as ablation of E4bp4
in NK cells does not affect NK cell numbers.26 Txnip is a stress–
response gene expressed from NK progenitors. NK progenitors,
as well as mature NK cell numbers, are reduced in Txnip2/2 mice,
correlating with decreased CD122 expression.27 Eomes2/2 mice
have reduced transition from early CD271CD11b– into in-
termediate CD271CD11b1NK cell stages, whereas T-bet2/2mice
have reduced NK cell numbers in the final CD27-CD11b1
stage.28,29 Mice deficient for both T-bet and Eomes have a
complete loss of NK cells in all organs.29 T-bet and Eomes thus
have both redundant and specific activities.28-34 Murine Ets1 in-
duces T-bet expression,5 whereas Eomes expression depends on
E4bp4.24 It is thus remarkable that human EOMES expression is
upregulated in response to ETS1 loss-of-function that, in contrast
to observations in the mouse, results in E4BP4 downregulation.
However, limited numbers of murine Eomes-positive tissue-
resident NK cells are still able to develop in the absence of
E4bp4, which suggests alternate molecular mechanisms for the
induction of Eomes expression.35-37 Also, Eomes and T-bet levels
correlate inversely in differentiating murine NK cells, suggesting
that negative feedback mechanisms regulate their balance,30,38
which possibly explains enhanced EOMES and decreased TBET
expression in human ETS1 p27NK cells. MurineGata32/2NK cells
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Figure 5. ETS1 p27 expression increases apoptosis in NK cells.
(A) NK cells were sorted from d14 control and ETS1 p27 cultures.
Quantitative polymerase chain reaction results are shown for the
relative expression of indicated proapoptotic and antiapoptotic
genes (mean 6 SEM; n 5 3-7). (B) NK cells from control and ETS1
p27 cultures were analyzed at d14 for apoptosis using annexin V and
propidium iodide (PI) staining. The percentage annexin V and/or PI-
positive cells in the NK cell gate is shown (mean6 SEM; n5 3-4). (C)
Database for Annotation, Visualization and Integrated Discovery
(DAVID) analysis of upregulated and downregulated genes of the
RNA-sequencing analysis of ETS1 p27 vs control NK cells. The 10
most significant pathways are shown. (D) The number of upregu-
lated and downregulated genes of ETS1 p27 vs control NK cells in
the Gene Ontology positive and negative regulation of the mitotic
cell cycle pathways. (E) Cell cycle analysis of d18 NK cells by 7-AAD/
Ki67 staining. The percentage of cells at the indicated cell cycle
phases is shown (n 5 4). Significant difference compared with
control, *P , .05 (Student t test). ATP, adenosine triphosphate; ctrl,
control.
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decreased NK cell numbers in peripheral organs.39,40 Gata3 de-
letion ablates generation of murine IL-7Ra1 thymic NK cells.41
Conventional murine Gata32/2 NK cells have decreased T-bet
expression.40
One of the most affected transcription factors in human ETS1
p27 NK cells is HOBIT. In mice, Hobit is highly expressed in liver
tissue–resident NK cells, whereas it is virtually absent in liver and
spleen conventional NK cells. In line with this, only murine liver
tissue–resident NK cells are Hobit dependent.42 In contrast to
murine findings, HOBIT is the most upregulated transcription
factor during NK cell differentiation from CB HPCs, and HOBIT
knockdown results in reduction of NK progenitors and largely
abrogates NK cell generation. The remaining NK cells exhibit
unaltered degranulation, whereas IFN-g production is increased.43
Blimp1, a homolog of Hobit, is required for terminal maturation
of murine spleen NK cells. Residual NK cells have an unaltered
capacity of IFN-g production and cytotoxicity in vitro, although
RMA-S tumor growth in vivo is increased.44 Although most NK-
linked transcription factors were repressed in ETS1 p27 NK cells,
expression of AIOLOS (IKZF3) and EOMES was significantly































































































































































































































































Figure 6. ETS1 influences NK cell terminal differentiation and function. (A-B) Flow cytometric expression of the indicated receptors on gated NK cells from d21 control (ctrl)
and ETS1 p27 cultures (mean6 SEM; n5 5-15). (C) d18 to d21NK cells were stimulated with an equal number of K562 target cells, and CD107a expression was determined (mean
6 SEM; n5 8). (D) The cytotoxic capacity of sorted d18 to d21 NK cells against K562 targets was determined in a 51chromium release assay. Data are expressed as the percent
specific lysis as a function of the effector:target ratio (mean 6 SEM; n 5 6). (E) The mean fluorescence intensity (MFI) of perforin and granzyme B (GzmB) expression in ctrl and
ETS1 p27 NK cells (n5 6). (F) Fas ligand expression of NK cells that were unstimulated (US) or stimulated for 2 hours with K562 cells (n5 5). (G) Cells from d21 ctrl and ETS1 p27
cultures were stimulated with K562 cells for 6 hours, or with IL-12/IL-18 or IL-12/IL-15/IL-18 for 24 hours, and IFN-g production was determined by flow cytometry in gated NK cells
(mean 6 SEM; n 5 4-12). (H) Sorted d21 NK cells were stimulated with IL-12/IL-18 or IL-12/IL-15/IL-18 for 24 hours, and secreted IFN-g was measured by using enzyme-linked
immunosorbent assay. The relative IFN-g production compared with ctrl is shown (mean 6 SEM; n 5 6-7). Significant difference compared with ctrl, *P , .05, **P , .01, and
***P , .001 (Student t test).
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lineage, and Ikzf32/2mice have a block in terminal differentiation.45
This differentiation block resembles that found inmice lacking T-bet
and Blimp1; however, mice lacking either T‐bet, Blimp1, or both
proteins have normal Aiolos expression, suggesting that Aiolos
functions at a different level in NK cell differentiation.45
Taken together, we have shown a remarkable influence of ETS1 on
expression of several transcription factors that have key roles in NK
cell development, as shown before by the generation of knockout
mice for these individual factors. Whereas the dominant-negative
ETS1 p27 isoform significantly reduces expression of each of these
6 key transcription factors in humanmodels, it does not completely
abolish expression. The severely compromised human NK cell
differentiation in the absence of functional ETS1 is therefore
presumably due to the synergistic effect of reduction of expression
of these different key NK cell–linked transcription factors. NK cells
in Ets12/2 mice also have decreased Tbet expression but, in
contrast to ETS1 p27 NK cells, have decreased Eomes and in-
creased E4bp4 and Helios expression. Also in contrast to findings
in Ets12/2 mice,5 we detected no difference in the other IKAROS
family member, HELIOS (IKZF2), in ETS1 p27 NK cells.
It can be argued that the dominant-negative ETS1 isoform also
affects binding and transcriptional regulation by other ETS family
proteins, as members of the ETS family are characterized by a well-
conserved DNA-binding domain. Approximately one-half of the
ETS members are significantly expressed in mature NK cells
(supplemental Table 3). However, in this context, it is important
that the full-length ETS1 (p51) is autoinhibited for its binding to
DNA due to the presence of 2 inhibitory domains surrounding and
interacting with its DNA-binding domain.46 To counteract auto-
inhibition and improve DNA binding, ETS1 interacts with partners,
enabling their cooperative binding to adjacent DNA elements.47
This binding autoinhibition brings an additional degree of com-
plexity and specificity in the transcriptional function of ETS1 p51
and enhances the specificity of ETS1 function comparedwith other
ETS proteins that are not autoinhibited. This compelling need for
partners is essential for ETS1 function and results in a particular
space-time function. Both inhibitory domains surrounding the
DNA-binding domain are conserved in ETS1 p27, suggesting that
ETS1 p27, as with the full-length ETS1 p51 isoform, is autoinhibited
for DNA binding. In this way, Ets-1 p27 may not be a dominant-
negative protein for other members of the ETS family.
To study the underlying cause of the lower NK cell number in
ETS1 p27 cultures, we tested both apoptosis as well as pro-
liferation. Apoptosis was significantly increased and correlated
with decreased expression of antiapoptotic genes that were also
direct ETS1 targets as shown by ChIP-seq, including TSC22D3,
BIRC3, and PIM2, as well as with increased expression of
proapoptotic genes such as PMAIP1. Both proapoptotic and
antiapoptotic features have been ascribed to ETS1, depending
on the biological context.48-51 Increased apoptosis also accounts
for the markedly decreased murine mature thymocyte and pe-
ripheral T-cell numbers generated from Ets12/2 precursors.52,53
Transcriptome analysis showed that although the mitosis path-
way was enriched in ETS1 p27 upregulated genes, the majority
of these genes negatively modulate mitosis. Cell cycle analysis
further showed that there was nomajor difference in ETS1 p27 vs
control NK cells. Overall, this indicates that the lower ETS1 p27
NK cell number is due to increased apoptosis rather than to a
difference in proliferation.
ETS1 has an important role in human NK cell terminal differ-
entiation and function as ETS1 p27 NK cells exhibit reduced
cytotoxicity and target cell–induced IFN-g production. The ac-
tivating receptors NKG2D, NKp30, NKp44, and NKp46 are
important to activate both NK cell cytotoxicity and cytokine
production upon tumor target recognition.54,55 Although
NKG2D expression was unaffected, expression of NKp30,
NKp44, and NKp46 was decreased in ETS1 p27 NK cells. In
addition, NK cells in Ets12/2 mice have unaffected expression of
NKG2D and decreased expression of NKp46.5 Human ETS1
ChIP peaks were present in promotors or enhancers of NCR1,
NCR2, and NCR3, which encode NKp46, NKp44, and NKp30,
respectively (supplemental Table 1). This suggests that ETS1
directly regulates expression of these activating NK cell re-
ceptors. In addition, the reduced ETS1 p27 NK cell functionality
can be enforced by the altered expression of several tran-
scription factors proven to be involved in functional maturation
of NK cells (ie, Aiolos, E4BP4, TXNIP, GATA3, T-bet). Murine
Aiolos2/2 NK cells display a hyperreactive response toward
tumor cells in vivo, suggesting a negative regulatory role of
Aiolos in NK cell activation.45 The enhanced AIOLOS expression
in human ETS1 p27 NK cells might therefore contribute to
decreased cytotoxicity. Murine E4bp42/2 and Txnip2/2 NK cells
show impaired cytotoxicity, and Gata3 and Txnip are required
for efficient IFN-g production.23,27,39 Also, T-bet has been de-
scribed as essential for functional maturation of murine NK
cells.28 Although TBET was repressed in ETS1 p27 NK cells, the
decreased cytotoxicity of murine T-bet2/2 NK cells has been
attributed to the decreased production of perforin and gran-
zyme B,29 whereas both perforin and granzyme B were increased
in human ETS1 p27 NK cells. Similarly, NK cells from Ets12/2
mice contain higher amounts of perforin and granzyme B.5
The current study provides mechanistic insight into the role of
ETS1 in human NK cell biology by showing that ETS1 loss-of-
function results in altered expression of 8 key transcription
factors that have been linked to NK cell development and ter-
minal differentiation in mouse and/or human. In addition, ETS1
loss-of-function leads to altered gene expression linked to in-
creased apoptosis and decreased expression of activating NK
cell receptors. Finally, cytotoxicity and IFN-g production are
decreased upon tumor cell contact.
The crucial role of ETS1 in development and function of not only
B or T cells but also of NK cells suggests that genetic aberrations
within the gene give rise to immune-related diseases. Genome-
wide association studies have identified single nucleotide
polymorphisms in or near the ETS1 gene or in ETS1-specific
binding motifs of target genes. Accordingly, ETS1 is regarded as
a locus of susceptibility for a wide range of autoimmune and
inflammatory disorders, including systemic lupus erythematosus,
rheumatoid arthritis, psoriasis, multiple sclerosis, ulcerative co-
litis, type 1 diabetes, and allergy.20,56 However, the causal re-
lationship between ETS1 and these disorders is still a subject of
future research.
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Villéger SI, et al. A thymic pathway of mouse
natural killer cell development characterized
by expression of GATA-3 and CD127 [pub-
lished correction appears in Nat Immunol.
2006;7(12):1343]. Nat Immunol. 2006;7(11):
1217-1224.
42. Mackay LK, Minnich M, Kragten NA, et al.
Hobit and Blimp1 instruct a universal tran-
scriptional program of tissue residency in
lymphocytes. Science. 2016;352(6284):
459-463.
43. Post M, Cuapio A, Osl M, et al. The tran-
scription factor ZNF683/HOBIT regulates
human NK-cell development. Front Immunol.
2017;8:535.
44. Kallies A, Carotta S, Huntington ND, et al. A
role for Blimp1 in the transcriptional network
controlling natural killer cell maturation.
Blood. 2011;117(6):1869-1879.
45. Holmes ML, Huntington ND, Thong RP, et al.
Peripheral natural killer cell maturation de-
pends on the transcription factor Aiolos.
EMBO J. 2014;33(22):2721-2734.
46. Lee GM, Donaldson LW, Pufall MA, et al. The
structural and dynamic basis of Ets-1 DNA
binding autoinhibition. J Biol Chem. 2005;
280(8):7088-7099.
47. Pufall MA, Graves BJ. Autoinhibitory do-
mains: modular effectors of cellular regula-
tion. Annu Rev Cell Dev Biol. 2002;18(1):
421-462.
48. Xu D,Wilson TJ, Chan D, et al. Ets1 is required
for p53 transcriptional activity in UV-induced
apoptosis in embryonic stem cells. EMBO J.
2002;21(15):4081-4093.
49. Teruyama K, Abe M, Nakano T, et al. Role of
transcription factor Ets-1 in the apoptosis of
human vascular endothelial cells. J Cell
Physiol. 2001;188(2):243-252.
50. Zhang C, Kavurma MM, Lai A, Khachigian LM.
Ets-1 protects vascular smooth muscle cells
from undergoing apoptosis by activating
p21WAF1/Cip1: ETS-1 regulates basal and
inducible p21WAF1/Cip: ETS-1 regulates
basal and inducible p21WAF1/Cip1 tran-
scription via distinct cis-acting elements in the
p21WAF/Cip1 promoter. J Biol Chem. 2003;
278(30):27903-27909.
51. Dittmer J. The role of the transcription factor
Ets1 in carcinoma. Semin Cancer Biol. 2015;
35(suppl C):20-38.
52. Muthusamy N, Barton K, Leiden JM. Defective
activation and survival of T cells lacking the
Ets-1 transcription factor. Nature. 1995;
377(6550):639-642.
53. Bories JC, Willerford DM, Grévin D, et al.
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